Cite
Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy
MLA
Elihu H. Estey, et al. “Intravenous Itraconazole for Prophylaxis of Systemic Fungal Infections in Patients with Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome Undergoing Induction Chemotherapy.” Cancer, vol. 100, Jan. 2004, pp. 568–73. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dd35fea34713975c5d173fc13ab25132&authtype=sso&custid=ns315887.
APA
Elihu H. Estey, Sherry Pierce, B. Nebiyou Bekele, Xian Zhou, Francis J. Giles, Stefan Faderl, Issam I Raad, Gerhard J. Leitz, Jo Ann Lim, Hagop M. Kantarjian, Jorge E. Cortes, Gloria Mattiuzzi, Dimitrios P. Kontoyiannis, & Susan O’Brien. (2004). Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy. Cancer, 100, 568–573.
Chicago
Elihu H. Estey, Sherry Pierce, B. Nebiyou Bekele, Xian Zhou, Francis J. Giles, Stefan Faderl, Issam I Raad, et al. 2004. “Intravenous Itraconazole for Prophylaxis of Systemic Fungal Infections in Patients with Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome Undergoing Induction Chemotherapy.” Cancer 100 (January): 568–73. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dd35fea34713975c5d173fc13ab25132&authtype=sso&custid=ns315887.